Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypertension RDN Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 r-Renal Denervation(rRDN)
1.2.3 u-Renal Denervation(uRDN)
1.3 Market by Application
1.3.1 Global Hypertension RDN Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypertension RDN Therapy Market Perspective (2018-2033)
2.2 Hypertension RDN Therapy Growth Trends by Region
2.2.1 Global Hypertension RDN Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hypertension RDN Therapy Historic Market Size by Region (2018-2023)
2.2.3 Hypertension RDN Therapy Forecasted Market Size by Region (2024-2033)
2.3 Hypertension RDN Therapy Market Dynamics
2.3.1 Hypertension RDN Therapy Industry Trends
2.3.2 Hypertension RDN Therapy Market Drivers
2.3.3 Hypertension RDN Therapy Market Challenges
2.3.4 Hypertension RDN Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypertension RDN Therapy Players by Revenue
3.1.1 Global Top Hypertension RDN Therapy Players by Revenue (2018-2023)
3.1.2 Global Hypertension RDN Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Hypertension RDN Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hypertension RDN Therapy Revenue
3.4 Global Hypertension RDN Therapy Market Concentration Ratio
3.4.1 Global Hypertension RDN Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypertension RDN Therapy Revenue in 2022
3.5 Hypertension RDN Therapy Key Players Head office and Area Served
3.6 Key Players Hypertension RDN Therapy Product Solution and Service
3.7 Date of Enter into Hypertension RDN Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypertension RDN Therapy Breakdown Data by Type
4.1 Global Hypertension RDN Therapy Historic Market Size by Type (2018-2023)
4.2 Global Hypertension RDN Therapy Forecasted Market Size by Type (2024-2033)
5 Hypertension RDN Therapy Breakdown Data by Application
5.1 Global Hypertension RDN Therapy Historic Market Size by Application (2018-2023)
5.2 Global Hypertension RDN Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hypertension RDN Therapy Market Size (2018-2033)
6.2 North America Hypertension RDN Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Hypertension RDN Therapy Market Size by Country (2018-2023)
6.4 North America Hypertension RDN Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hypertension RDN Therapy Market Size (2018-2033)
7.2 Europe Hypertension RDN Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Hypertension RDN Therapy Market Size by Country (2018-2023)
7.4 Europe Hypertension RDN Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hypertension RDN Therapy Market Size (2018-2033)
8.2 Asia-Pacific Hypertension RDN Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Hypertension RDN Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Hypertension RDN Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hypertension RDN Therapy Market Size (2018-2033)
9.2 Latin America Hypertension RDN Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Hypertension RDN Therapy Market Size by Country (2018-2023)
9.4 Latin America Hypertension RDN Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypertension RDN Therapy Market Size (2018-2033)
10.2 Middle East & Africa Hypertension RDN Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Hypertension RDN Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Hypertension RDN Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Hypertension RDN Therapy Introduction
11.1.4 Medtronic Revenue in Hypertension RDN Therapy Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 ReCor Medical
11.2.1 ReCor Medical Company Detail
11.2.2 ReCor Medical Business Overview
11.2.3 ReCor Medical Hypertension RDN Therapy Introduction
11.2.4 ReCor Medical Revenue in Hypertension RDN Therapy Business (2018-2023)
11.2.5 ReCor Medical Recent Development
11.3 Sonivies
11.3.1 Sonivies Company Detail
11.3.2 Sonivies Business Overview
11.3.3 Sonivies Hypertension RDN Therapy Introduction
11.3.4 Sonivies Revenue in Hypertension RDN Therapy Business (2018-2023)
11.3.5 Sonivies Recent Development
11.4 Covidien
11.4.1 Covidien Company Detail
11.4.2 Covidien Business Overview
11.4.3 Covidien Hypertension RDN Therapy Introduction
11.4.4 Covidien Revenue in Hypertension RDN Therapy Business (2018-2023)
11.4.5 Covidien Recent Development
11.5 Boston Scientific
11.5.1 Boston Scientific Company Detail
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Hypertension RDN Therapy Introduction
11.5.4 Boston Scientific Revenue in Hypertension RDN Therapy Business (2018-2023)
11.5.5 Boston Scientific Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Hypertension RDN Therapy Introduction
11.6.4 Johnson & Johnson Revenue in Hypertension RDN Therapy Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Terumo Corporation
11.7.1 Terumo Corporation Company Detail
11.7.2 Terumo Corporation Business Overview
11.7.3 Terumo Corporation Hypertension RDN Therapy Introduction
11.7.4 Terumo Corporation Revenue in Hypertension RDN Therapy Business (2018-2023)
11.7.5 Terumo Corporation Recent Development
11.8 Angiocare
11.8.1 Angiocare Company Detail
11.8.2 Angiocare Business Overview
11.8.3 Angiocare Hypertension RDN Therapy Introduction
11.8.4 Angiocare Revenue in Hypertension RDN Therapy Business (2018-2023)
11.8.5 Angiocare Recent Development
11.9 Shanghai Golden Leaf Med Tec
11.9.1 Shanghai Golden Leaf Med Tec Company Detail
11.9.2 Shanghai Golden Leaf Med Tec Business Overview
11.9.3 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Introduction
11.9.4 Shanghai Golden Leaf Med Tec Revenue in Hypertension RDN Therapy Business (2018-2023)
11.9.5 Shanghai Golden Leaf Med Tec Recent Development
11.10 Shanghai Bio-Heart Biological Technology
11.10.1 Shanghai Bio-Heart Biological Technology Company Detail
11.10.2 Shanghai Bio-Heart Biological Technology Business Overview
11.10.3 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Introduction
11.10.4 Shanghai Bio-Heart Biological Technology Revenue in Hypertension RDN Therapy Business (2018-2023)
11.10.5 Shanghai Bio-Heart Biological Technology Recent Development
11.11 Xinmai Medical Equipment
11.11.1 Xinmai Medical Equipment Company Detail
11.11.2 Xinmai Medical Equipment Business Overview
11.11.3 Xinmai Medical Equipment Hypertension RDN Therapy Introduction
11.11.4 Xinmai Medical Equipment Revenue in Hypertension RDN Therapy Business (2018-2023)
11.11.5 Xinmai Medical Equipment Recent Development
11.12 Microport Ep Medtech
11.12.1 Microport Ep Medtech Company Detail
11.12.2 Microport Ep Medtech Business Overview
11.12.3 Microport Ep Medtech Hypertension RDN Therapy Introduction
11.12.4 Microport Ep Medtech Revenue in Hypertension RDN Therapy Business (2018-2023)
11.12.5 Microport Ep Medtech Recent Development
11.13 Cryofocus Medtech
11.13.1 Cryofocus Medtech Company Detail
11.13.2 Cryofocus Medtech Business Overview
11.13.3 Cryofocus Medtech Hypertension RDN Therapy Introduction
11.13.4 Cryofocus Medtech Revenue in Hypertension RDN Therapy Business (2018-2023)
11.13.5 Cryofocus Medtech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hypertension RDN Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of r-Renal Denervation(rRDN)
Table 3. Key Players of u-Renal Denervation(uRDN)
Table 4. Global Hypertension RDN Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Hypertension RDN Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Hypertension RDN Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hypertension RDN Therapy Market Share by Region (2018-2023)
Table 8. Global Hypertension RDN Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Hypertension RDN Therapy Market Share by Region (2024-2033)
Table 10. Hypertension RDN Therapy Market Trends
Table 11. Hypertension RDN Therapy Market Drivers
Table 12. Hypertension RDN Therapy Market Challenges
Table 13. Hypertension RDN Therapy Market Restraints
Table 14. Global Hypertension RDN Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hypertension RDN Therapy Market Share by Players (2018-2023)
Table 16. Global Top Hypertension RDN Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension RDN Therapy as of 2022)
Table 17. Ranking of Global Top Hypertension RDN Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Hypertension RDN Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hypertension RDN Therapy Product Solution and Service
Table 21. Date of Enter into Hypertension RDN Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hypertension RDN Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hypertension RDN Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Hypertension RDN Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Hypertension RDN Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Hypertension RDN Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hypertension RDN Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Hypertension RDN Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Hypertension RDN Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Hypertension RDN Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Hypertension RDN Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Hypertension RDN Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Hypertension RDN Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Hypertension RDN Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Hypertension RDN Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Hypertension RDN Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Hypertension RDN Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Hypertension RDN Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Hypertension RDN Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Hypertension RDN Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Hypertension RDN Therapy Product
Table 49. Medtronic Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. ReCor Medical Company Detail
Table 52. ReCor Medical Business Overview
Table 53. ReCor Medical Hypertension RDN Therapy Product
Table 54. ReCor Medical Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 55. ReCor Medical Recent Development
Table 56. Sonivies Company Detail
Table 57. Sonivies Business Overview
Table 58. Sonivies Hypertension RDN Therapy Product
Table 59. Sonivies Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 60. Sonivies Recent Development
Table 61. Covidien Company Detail
Table 62. Covidien Business Overview
Table 63. Covidien Hypertension RDN Therapy Product
Table 64. Covidien Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 65. Covidien Recent Development
Table 66. Boston Scientific Company Detail
Table 67. Boston Scientific Business Overview
Table 68. Boston Scientific Hypertension RDN Therapy Product
Table 69. Boston Scientific Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 70. Boston Scientific Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Hypertension RDN Therapy Product
Table 74. Johnson & Johnson Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Terumo Corporation Company Detail
Table 77. Terumo Corporation Business Overview
Table 78. Terumo Corporation Hypertension RDN Therapy Product
Table 79. Terumo Corporation Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 80. Terumo Corporation Recent Development
Table 81. Angiocare Company Detail
Table 82. Angiocare Business Overview
Table 83. Angiocare Hypertension RDN Therapy Product
Table 84. Angiocare Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 85. Angiocare Recent Development
Table 86. Shanghai Golden Leaf Med Tec Company Detail
Table 87. Shanghai Golden Leaf Med Tec Business Overview
Table 88. Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product
Table 89. Shanghai Golden Leaf Med Tec Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 90. Shanghai Golden Leaf Med Tec Recent Development
Table 91. Shanghai Bio-Heart Biological Technology Company Detail
Table 92. Shanghai Bio-Heart Biological Technology Business Overview
Table 93. Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product
Table 94. Shanghai Bio-Heart Biological Technology Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 95. Shanghai Bio-Heart Biological Technology Recent Development
Table 96. Xinmai Medical Equipment Company Detail
Table 97. Xinmai Medical Equipment Business Overview
Table 98. Xinmai Medical Equipment Hypertension RDN Therapy Product
Table 99. Xinmai Medical Equipment Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 100. Xinmai Medical Equipment Recent Development
Table 101. Microport Ep Medtech Company Detail
Table 102. Microport Ep Medtech Business Overview
Table 103. Microport Ep Medtech Hypertension RDN Therapy Product
Table 104. Microport Ep Medtech Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 105. Microport Ep Medtech Recent Development
Table 106. Cryofocus Medtech Company Detail
Table 107. Cryofocus Medtech Business Overview
Table 108. Cryofocus Medtech Hypertension RDN Therapy Product
Table 109. Cryofocus Medtech Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 110. Cryofocus Medtech Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypertension RDN Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Hypertension RDN Therapy Market Share by Type: 2022 VS 2033
Figure 3. r-Renal Denervation(rRDN) Features
Figure 4. u-Renal Denervation(uRDN) Features
Figure 5. Global Hypertension RDN Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Hypertension RDN Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Hypertension RDN Therapy Report Years Considered
Figure 11. Global Hypertension RDN Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Hypertension RDN Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Hypertension RDN Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Hypertension RDN Therapy Market Share by Players in 2022
Figure 15. Global Top Hypertension RDN Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension RDN Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Hypertension RDN Therapy Revenue in 2022
Figure 17. North America Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Hypertension RDN Therapy Market Share by Country (2018-2033)
Figure 19. United States Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Hypertension RDN Therapy Market Share by Country (2018-2033)
Figure 23. Germany Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Hypertension RDN Therapy Market Share by Region (2018-2033)
Figure 31. China Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Hypertension RDN Therapy Market Share by Country (2018-2033)
Figure 39. Mexico Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Hypertension RDN Therapy Market Share by Country (2018-2033)
Figure 43. Turkey Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Medtronic Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 46. ReCor Medical Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 47. Sonivies Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 48. Covidien Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 49. Boston Scientific Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 51. Terumo Corporation Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 52. Angiocare Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 53. Shanghai Golden Leaf Med Tec Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 54. Shanghai Bio-Heart Biological Technology Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 55. Xinmai Medical Equipment Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 56. Microport Ep Medtech Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 57. Cryofocus Medtech Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed